Coherus Oncology, Inc.
CHRS Healthcare Biotechnology
In the quarter to June 2026, revenue grew 39.5%, EPS fell 105.1%, free cash flow fell 33.2% and total debt rose 1.03%, each against the same quarter a year earlier.
Follow CHRS
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
105.31 | 167.05 | 172.13 | 191.66 |
+8 more quarters Free account |
Receivables |
14.25 | 22.51 | 18.42 | 250.50 | |
Inventory |
5.67 | 4.83 | 3.17 | 2.05 | |
Other current assets |
5.35 | 9.38 | 6.23 | 8.70 | |
Total current assets |
133.79 | 206.04 | 206.71 | 460.96 | |
Property, Plant, Equpment (Net) |
0.87 | 1.09 | 1.35 | 1.63 | |
Goodwill and Intangible Assets (Total) |
44.99 | 45.61 | 46.24 | 49.48 | |
Long-term assets (Other) |
3.12 | 3.59 | 4.05 | 4.45 | |
Total non-current assets |
57.40 | 59.99 | 51.64 | 55.56 | |
Total Assets |
191.18 | 266.02 | 258.34 | 516.52 | |
Accounts Payable |
13.17 | 11.48 | 9.92 | 24.89 | |
Accrued Expenses |
62.34 | 120.85 | 130.47 | 347.40 | |
Total current liabilities |
75.51 | 132.33 | 140.39 | 372.30 | |
Long Term Debt (Total) |
37.25 | 37.15 | 37.05 | 36.96 | |
Non-current Liabilities (Other) |
17.59 | 16.97 | 19.89 | 17.55 | |
Total non-current liabilities |
54.84 | 55.07 | 56.94 | 56.45 | |
Total liabilities |
130.35 | 187.40 | 197.33 | 428.75 | |
Additional Paid In Capital |
1,503.03 | 1,500.17 | 1,444.17 | 1,433.29 | |
Common Stock (Net) |
0.02 | 0.02 | 0.01 | 0.01 | |
Retained Earnings |
(1,441.93) | (1,421.30) | (1,382.97) | (1,345.33) | |
Common Equity (Total) |
60.84 | 78.62 | 61.01 | 87.77 | |
Shareholders Equity (Total) |
60.84 | 78.62 | 61.01 | 87.77 | |
Shareholders Equity and Liabilities (Total) |
191.18 | 266.02 | 258.34 | 516.52 | |
Shares (Common) |
154.47 | 154.22 | 121.16 | 116.24 | |
Shareholders Equity (Tangible) |
15.85 | 33.01 | 14.78 | 38.29 | |
Net Debt |
(68.06) | (129.90) | (135.07) | (154.71) | |
Total Debt |
37.25 | 37.15 | 37.05 | 36.96 |